Evaluation Of A New Vitamin E-Bonded Membrane On Anemia And Oxidative Stress In End-Stage Renal Disease Patients
NCT00687258 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2020-09-25
Summary
The main purpose of this longitudinal study is to point out the effect of VitabranE on the ESA resistance and on the anemia observed in HD patients undergoing EPO maintenance therapy.
As a secondary purpose we will consider the effect of VitabranE on inflammation and oxidative stress parameters as a function of the changes observed in the anemia parameters.
Conditions
Interventions
- DEVICE
-
VitabranE ViE
Polysulfone dialyser with vitamin E alpha-tocopherol
Sponsors & Collaborators
-
A. Manzoni Hospital
lead OTHER
Principal Investigators
-
Francesco Locatelli, MD · Nephrology and Dialysis Department - A. Manzoni Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-07-31
- Primary Completion
- 2007-03-31
- Completion
- 2007-07-31
Countries
- Italy
Study Locations
More Related Trials
-
Study of the Effect of Synchronised Anaemia Management in Chronic Kidney Disease
NCT01763242 ·Status: COMPLETED ·Phase: PHASE4
-
Phase III Study of GSK1278863 in Japanese Non-dialysis (ND) and Peritoneal Dialysis (PD) Subjects With Renal Anemia
NCT02791763 ·Status: COMPLETED ·Phase: PHASE3
-
Randomized, Controlled, Double-blind Multicenter Safety Study to Evaluate the Safety and Immunogenicity of Subcutaneous EPO HEXAL vs. ERYPO® in the Treatment of Anemia Associated With Chronic Renal Insufficiency in Predialysis Patients
NCT00701714 ·Status: TERMINATED ·Phase: PHASE3
-
A Study of the Efficacy and Safety of MK2578 for the Treatment of Anemia in Patients With Kidney Disease (MK2578-003-AM03-EXT12)
NCT00924781 ·Status: TERMINATED ·Phase: PHASE2
-
4 Week Switch Study in Hemodialysis-dependent Subjects With Anemia Associated With Chronic Kidney Disease
NCT01587924 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Subcutaneous C.E.R.A. for the Treatment of Anemia in Pre-Dialysis Patients.
NCT00576628 ·Status: COMPLETED ·Phase: PHASE3
-
Epodure Therapy of Anemia in End Stage Renal Disease on Dialysis With Epodure Skin Implant
NCT01555515 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Audit of the Effect of Changing From IV to SC Administration of ESA's in Haemodialysis Patients
NCT00382044 ·Status: COMPLETED
-
Comparison Study of Two Iron Compounds for Treatment of Anemia in Hemodialysis Patients
NCT02198495 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of PEG-EPO Injection (CHO Cells) for Maintenance Therapy of Patients With Renal Anemia .
NCT05629598 ·Status: UNKNOWN ·Phase: PHASE2
-
Safety & Efficacy of EPO-018B for the Treatment of Anemia in Participants With ERSD Receiving Maintenance Hemodialysis
NCT02366325 ·Status: UNKNOWN ·Phase: PHASE2
-
Renal Prognosis in Chronic Kidney Disease Patients With Hyporesponsive Anemia to Erythropoiesis Stimulating Agents
NCT02136563 ·Status: COMPLETED
-
Comparing Efficacy and Safety of CinnaGen Beta Erythropoietin (CinnaPoietin®) Versus Eprex® on the Treatment of Anemia in ESRD Hemodialysis Patients
NCT03408639 ·Status: COMPLETED ·Phase: PHASE3
-
Biosimilar Erythropoietin in Anaemia Treatment (Correction Phase Study)
NCT02522975 ·Status: TERMINATED ·Phase: PHASE4
-
FG-4592 for Treatment of Anemia in Subjects With Chronic Kidney Disease
NCT02652806 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate Safety and Efficacy of GSK1278863 in Non-Dialysis Dependent (NDD) Subjects With Anemia Associated With Chronic Kidney Diseases (CKD)
NCT01977573 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Epoetin Beta (NeoRecormon) in Anemic Participants With Diabetes and Chronic Renal Failure Who Are Not on Dialysis
NCT02827266 ·Status: COMPLETED ·Phase: PHASE3
-
Levocarnitine for Reducing ESA Requirements in Hemodialysis Patients With Renal Anemia
NCT07160452 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Safety and Efficacy of Sustained Erythropoietin Therapy
NCT00542568 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
4 Week Correction Study in Subjects With Anemia Associated With Chronic Kidney Disease Who Are Not Undergoing Dialysis
NCT01587898 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment Response in Dialysis Anaemia
NCT02707757 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Three-times Weekly Dosing of GSK1278863 in Hemodialysis-dependent Subjects With Anemia Associated With Chronic Kidney Disease Who Are Switched From a Stable Dose of an Erythropoiesis-stimulating Agent
NCT02689206 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase 3, Long-Term Safety Study of Subcutaneous Epoetin Hospira in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME -Anemia Management With Epoetin
NCT01628120 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy & Safety Study of Recombinant Human Erythropoietin -Alpha, in Patients With Anemia of Chronic Renal Failure
NCT00399269 ·Status: COMPLETED ·Phase: PHASE3
-
Study of rESP Injection for the Treatment of Anemia in Chronic Renal Failure Patients With Hemodialysis
NCT03950687 ·Status: UNKNOWN ·Phase: PHASE2